PHARMACOKINETICS OF REPEATED SINGLE ORAL DOSES OF ENALAPRIL MALEATE (MK-421) IN NORMAL VOLUNTEERS

被引：101

作者：

TILL, AE

GOMEZ, HJ

HICHENS, M

BOLOGNESE, JA

MCNABB, WR

BROOKS, BA

NOORMOHAMED, F

LANT, AF

机构：

[1] MERCK SHARP & DOHME RES LABS,RAHWAY,NJ 07065

[2] WESTMINSTER HOSP,DEPT THERAPEUT,LONDON SW1P 2AP,ENGLAND

来源：

BIOPHARMACEUTICS & DRUG DISPOSITION | 1984年 / 5卷 / 03期

关键词：

D O I：

10.1002/bdd.2510050309

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：273 / 280

页数：8

共 11 条

[1] ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF A NEW CONVERTING ENZYME-INHIBITOR, ENALAPRIL [J].

CHRYSANT, SG ;

BROWN, RD ;

KEM, DC ;

BROWN, JL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) :741-746

[2]

GAVRAS H, 1981, LANCET, V2, P543

[3]

Gomez H J, 1983, J Hypertens Suppl, V1, P65

[4]

GROSS DM, 1981, J PHARMACOL EXP THER, V216, P552

[5]

HICHENS M, 1981, Ligand Quarterly, V4, P43

[6] CONVERTING-ENZYME INHIBITOR ENALAPRIL (MK421) IN TREATMENT OF HYPERTENSION WITH RENAL-ARTERY STENOSIS [J].

HODSMAN, GP ;

BROWN, JJ ;

DAVIES, DL ;

FRASER, R ;

LEVER, AF ;

MORTON, JJ ;

MURRAY, GD ;

ROBERTSON, JIS .

BMJ-BRITISH MEDICAL JOURNAL, 1982, 285 (6356) :1697-1699

[7]

KWAN KC, PHARMACOKINETICS MOD

[8]

SWEET CS, 1981, J PHARMACOL EXP THER, V216, P558

[9]

TILL AE, 1982, 83RD AM SOC CLIN PHA

[10] ENALAPRIL MALEATE (MK-421), A POTENT, NONSULFHYDRYL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - ABSORPTION, DISPOSITION, AND METABOLISM IN MAN [J].

ULM, EH .

DRUG METABOLISM REVIEWS, 1983, 14 (01) :99-110

← 1 2 →